Chinese Herbal Medicine in the Treatment of G.I. Cancer: From Bench to Bedside
Jan 5, 2010: Edward Chu, M.D.
The Yale HEROS Clinic: A Clinical and Research Program for Childhood Cancer Survivors
Feb 2, 2010: Nina S. Kadan-Lottick, M.D., M.S.P.H.
Stemness, Inflammation and Tumor Immunity: From Bedside to the Bench and Back
Feb 23, 2010: Madhav Dhodapkar
Targeting and Mistargeting of Somatic Hypermutation: Implications for Lymphomagenesis
Feb 23, 2010: David G. Schatz, Ph.D.
Traptamers: Artificial Proteins that Modulate Cell Behavior
March 9, 2010: Daniel C. DiMaio, M.D., Ph.D.
Understanding Castrate Resistant Prostate Cancer: Era of New Hope
March 9, 2010: William Kevin Kelly, D.O.
Non-invasive Assessment of Dermal Carotenoids by Resonance Raman Spectroscopy as a Biomarker of Nutritional Status in Epidemiologic Research
March 16, 2010: Susan T. Mayne, Ph.D., F.A.C.E.
Causes and Consequences of Genetic Abnormalities in Chronic Lymphocytic Leukemia
March 23, 2010: Matthew P. Strout, M.D., Ph.D.
Pre-clinical versus Clinical Development of Novel Therapies for Melanoma-What Should Be The Chicken and What The Egg?
April 13, 2010: Harriet Kluger, M.D.
Thyroid Cancer and the Controversy Currently Surrounding Neck Dissection
June 1, 2010: Robert Udelsman, MBA, MD
Probing Abl Tyrosine Kinase Function in vivo using C. elegans genetics
June 29, 2010: Michael E. Hurwitz, M.D., Ph.D.
Errors in Delivery of Cancer Genetics Services: Implications for Practice
Sept 14, 2010: Ellen Matloff, MS
Oxaliplatin Neurotoxicity and Biologics: Maximizing Clinical Benefit
Sept 14, 2010: Howard Hochster, MD
OncomiR Addiction and the Potential for Targeting microRNAs in Cancer
Sept 21, 2010: Frank Slack, PhD
Genetic Variants in the Base Excision Repair Pathway and Cancer Risk
Nov 16, 2010: Joann Sweasy, PhD
The Cause of an Epidemic of Non-Hodgkin’s Lymphoma: What Do We Know 20 Years Later?
Nov 16, 2010: Tongzhang Zheng, DSc